Walgreens Boots Alliance Inc. (NASDAQ:WBA) will post its Q416 quarterly earnings results on Thursday, October 20th. Analysts expect Walgreens Boots Alliance to post earnings of $0.99 per share and revenue of $29.11 billion for the quarter.

Earnings History for Walgreens Boots Alliance (NASDAQ:WBA)

Walgreens Boots Alliance Inc. (NASDAQ:WBA) opened at 78.08 on Wednesday. The stock has a market capitalization of $84.51 billion, a price-to-earnings ratio of 26.98 and a beta of 1.01. Walgreens Boots Alliance Inc. has a 52-week low of $71.50 and a 52-week high of $95.74. The firm has a 50-day moving average price of $80.72 and a 200 day moving average price of $80.91.

The business also recently declared a quarterly dividend, which will be paid on Monday, December 12th. Shareholders of record on Thursday, November 17th will be issued a $0.375 dividend. The ex-dividend date is Tuesday, November 15th. This represents a $1.50 annualized dividend and a dividend yield of 1.92%. Walgreens Boots Alliance’s dividend payout ratio is currently 51.90%.

In related news, Director William C. Foote sold 2,067 shares of the stock in a transaction dated Tuesday, July 26th. The shares were sold at an average price of $81.35, for a total value of $168,150.45. Following the completion of the transaction, the director now owns 26,690 shares of the company’s stock, valued at $2,171,231.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Kathleen Wilson-Thompson sold 23,996 shares of the stock in a transaction dated Thursday, September 8th. The stock was sold at an average price of $85.00, for a total transaction of $2,039,660.00. The disclosure for this sale can be found here. Insiders own 21.10% of the company’s stock.

Hedge funds and other institutional investors have recently bought and sold shares of the company. MEMBERS Trust Co acquired a new position in Walgreens Boots Alliance during the second quarter valued at about $304,000. Sullivan Bruyette Speros & Blaney Inc. acquired a new position in Walgreens Boots Alliance during the second quarter valued at about $349,000. Peapack Gladstone Financial Corp raised its position in Walgreens Boots Alliance by 2.4% in the second quarter. Peapack Gladstone Financial Corp now owns 4,215 shares of the pharmacy operator’s stock valued at $351,000 after buying an additional 100 shares during the period. Allstate Corp acquired a new position in Walgreens Boots Alliance during the second quarter valued at about $367,000. Finally, Laurel Wealth Advisors Inc. acquired a new position in Walgreens Boots Alliance during the second quarter valued at about $383,000. 59.76% of the stock is owned by hedge funds and other institutional investors.

Several research analysts have issued reports on WBA shares. Bank of America Corp. reaffirmed a “buy” rating and issued a $94.00 price target on shares of Walgreens Boots Alliance in a report on Tuesday, August 30th. Deutsche Bank AG lifted their price objective on shares of Walgreens Boots Alliance from $93.00 to $94.00 and gave the stock a “buy” rating in a research report on Tuesday, August 30th. Evercore ISI reiterated a “buy” rating and set a $93.00 price objective on shares of Walgreens Boots Alliance in a research report on Thursday, July 7th. Credit Suisse Group AG reiterated a “buy” rating and set a $82.51 price objective (down from $95.00) on shares of Walgreens Boots Alliance in a research report on Monday, July 18th. Finally, JPMorgan Chase & Co. reiterated a “buy” rating on shares of Walgreens Boots Alliance in a research report on Thursday, July 7th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $93.35.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

5 Day Chart for NASDAQ:WBA

Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.